Havn Life Science | Company Profile
CSE: CMPS
Latest Sector Updates
Havn Life is targeting the advancement and formulation of regulated and novel psychoactive compounds. The company has secured a Health Canada exemption which allows for the research and development of psychedelic compounds. Havn retail is developing supplements that support health and wellness.
Havn listed in September 2020.
Stock information
Contact Information
Latest Havn Life News
HAVN Life Announces Departure of Rick Brar as Director
Canada NewsWire VANCOUVER, BC, Oct. 25, 2021 VANCOUVER, BC , Oct. 25, 2021 /CNW/ – HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the ” Company ” or ” HAVN Life “) ...
HAVN Life Files Final Base Shelf Prospectus
VANCOUVER, BC, Oct. 7, 2021 VANCOUVER, BC , Oct. 7, 2021 /CNW/ – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) is pleased to ...
HAVN Life Provides an Update on its Operations
Canada NewsWire VANCOUVER, BC , Oct. 1, 2021 /CNW/ – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP)  (the “Company” or “Havn Life”) provides an update on its operations. On August ...
HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations
VANCOUVER, BC, Sept. 29, 2021 Along with adding new formulations to the Company’s natural health product portfolio, founder Matthew Bennett to join HAVN Life as Director of ...
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
The partnership is a integral step in the The Company’s path to market in the U.S., achieving one of its most important milestones to-date VANCOUVER, ...
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized ...
